3.8 Article

Quality of life assessment in Egyptian rheumatoid arthritis patients: Relation to clinical features and disease activity

Journal

EGYPTIAN RHEUMATOLOGIST
Volume 38, Issue 2, Pages 65-70

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejr.2015.04.002

Keywords

Rheumatoid arthritis (RA); Health related quality of life (HRQoL); Medical Outcomes Study 36-Item short form health survey (SF-36); DAS28-predictors

Categories

Ask authors/readers for more resources

Aim of work: To assess the impact of rheumatoid arthritis (RA) on the health related quality of life (QoL) of patients, using the 36-item short form (SF-36) and to study the influence of different disease variables. Patients and methods: Eighty-six RA patients were recruited from the Rheumatology and Rehabilitation outpatient of Assiut University Hospital. Forty-three, age and sex matched subjects were included as controls. The QoL was measured in all subjects using the SF-36 health survey. Disease activity was assessed in RA patients by the disease activity score (DAS28). Results: All domains of the SF36 were significantly lower in the patients (p < 0.0001). Patients with a lower educational level and those unemployed had significantly lower SF36 components. Those with a disease duration > 5 years, positive rheumatoid factor and higher disease activity had a significantly lower SF36 physical component. Patients receiving hydroxychloroquine or prednisolone had significantly lower mental component. Significant negative correlation of the SF36 physical and mental components was found with both disease duration (p = 0.01 and p< 00001 respectively) and DAS28 (p< 0.0001 for both). Rheumatoid factor negatively correlated with the physical component (p< 0.0001). Regression analysis showed that disease duration was the most profound predictor of both SF36 components (p< 0.0001). Conclusion: The quality of life is impaired in Egyptian RA patients and disease duration was the most significant predictor. Routine assessment of the health-related QoL in those patients is recommended to detect and monitor the impact of the disease and medications used on different aspects of their quality of life. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available